Trials / Completed
CompletedNCT00788229
Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome
A Phase II, Randomized, Double-Blind, Clinical Trial to Evaluate the Efficacy and Safety of DHP-101, DHP-300, DHP-500 in Patients With Dry Eye Syndrome
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Dhp Korea Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether artificial tears are safe and effective in the treatment of Dry Eye Syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AT01 | eye drop for 12 weeks |
| DRUG | AT02 | eye drop for 12 weeks |
| DRUG | AT03 | eye drop for 12 weeks |
| DRUG | AT04 | eye drop for 12 weeks |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2009-08-01
- Completion
- 2009-08-01
- First posted
- 2008-11-10
- Last updated
- 2010-04-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00788229. Inclusion in this directory is not an endorsement.